Anagenesis Biotechnologies (FR)

https://www.anagenesis-biotech.com

Anagenesis Biotechnologies is a private company developing new treatments against muscle diseases (genetic such as DMD and chronic such as sarcopenia and cachexia). The company was cofounded by Dr. Olivier Pourquié, a worldwide key opinion leader in the field of musculoskeletal development and stem cells. Olivier Pourquié is a Professor at Harvard Medical School and the Brigham and Women’s Hospital and a member of the Harvard Stem Cell Institute. Anagenesis Biotechnologies is backed by a solid, experienced team led by its President & CEO, Dr. Jean-Yves Bonnefoy, coming from the Pharma & Biotech industry. Anagenesis Biotechnologies in Illkirch, France, is now focusing on HTS and HCS screens, while its newly formed US-subsidiary in Boston, MA, Anagenesis Biotherapies Inc., is developing the cell therapy approaches. *

	Start	2016-06-08 existent
	Group	Anagenesis (Group)
	Today	Anagenesis (Group)
	Industry	P2MC technology (Paraxial Mesoderm Multipotent Cells)
	Industry 2	cell therapy
	Person	Bonnefoy, Jean-Yves (Anangesis 201606 CEO before ElsaLys 201305– CEO + Co-founder before Transgene)

	Region	Illkirch
	Country	France
	Street	650 Boulevard Gonthier d’Andernach Parc d’Innovation d’Illkirch
	City	67400 Illkirch Graffenstaden
	Tel	+33-3-8843-1008
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Anagenesis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)